发明授权
- 专利标题： NOVEL COMPOUNDS
- 专利标题（中）： NEER VERBINDUNGEN
-
申请号： EP01929345.5申请日： 2001-02-16
-
公开(公告)号： EP1265915B1公开(公告)日： 2010-11-10
- 发明人: CABEZON-SILVA, T.E.V., SmithKline Beecham Bio. SA , CASSART, J.P., SmithKline Beecham Biologicals SA , COCHE, Thierry, SmithKline Beecham Biologicals SA , GAULIS, S.R.J.T., SmithKline Beecham Bio. SA , VINALS Y DE BASSOLS, C., SmithKline Beecham Bio.SA
- 申请人： GlaxoSmithKline Biologicals s.a.
- 申请人地址： rue de l'Institut 89 1330 Rixensart BE
- 专利权人： GlaxoSmithKline Biologicals s.a.
- 当前专利权人： GlaxoSmithKline Biologicals s.a.
- 当前专利权人地址： rue de l'Institut 89 1330 Rixensart BE
- 代理机构： Dalton, Marcus Jonathan William
- 优先权： GB0004269 20000223; GB0009905 20000420; GB0021080 20000825
- 国际公布： WO2001062778 20010830
- 主分类号： C07K14/00
- IPC分类号： C07K14/00
摘要：
CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal cancers, autoimmune diseases, and related conditions.
公开/授权文献
- EP1265915A2 NOVEL COMPOUNDS 公开/授权日：2002-12-18
信息查询
